Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies

Saved in:
Bibliographic Details
Published inBlood advances Vol. 7; no. 11; pp. 2459 - 2462
Main Authors Chang, Andres, Koff, Jean L., Lai, Lilin, Orellana-Noia, Victor M., Surati, Minal, Leal, Alyssa M. K., Ellis, Madison L., Wali, Bushra, Moreno, Alberto, Linderman, Susanne L., O’Leary, Colin B., Allen, Pamela B., Churnetski, Michael C., Dhodapkar, Madhav V., Suthar, Mehul S., Cohen, Jonathon B., Ahmed, Rafi
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 13.06.2023
by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved
Subjects
Antibodies, Monoclonal
COVID-19
Humans
Research Letter
SARS-CoV-2
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2473-9529
2473-9537
DOI:10.1182/bloodadvances.2022009475